Please assess the completion status of the following clinical trial:

Trial Title: Duloxetine Compared With Placebo in Patients With Generalized Anxiety Disorder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male and female outpatients at least 18 years of age~Exclusion Criteria:~* Have previously completed or withdrawn from this study or any other study investigating duloxetine or have previously been treated with duloxetine~* Patient diagnosed with major depressive disorder within the past 6 months~* Patient diagnosed with panic disorder, post-traumatic stress disorder, or an eating disorder within the past year~* History of alcohol or any psychoactive substance abuse or dependence within the past 6 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).